Cravath represented the underwriters, led by Citigroup, J.P. Morgan Securities, Barclays, Credit Suisse, HSBC, RBC Capital Markets, Bank of America Merrill Lynch and Deutsche Bank Securities, in connection with the €450 million registered high-yield senior notes offering of The Chemours Company, a leading global provider of performance chemicals. The notes were listed on the Irish Stock Exchange. Cravath also represented the dealer manager in connection with The Chemours Company's concurrent cash tender offers. The transaction closed on June 6, 2018.
The Cravath team included partners Craig F. Arcella and Nicholas A. Dorsey and associates Derrick M. Davis and Samuel A. Lifton on securities matters.